Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beraprost in chronic allograft nephropathy
NCT01056835Phase 3Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jun 2009
- Primary completion
- Dec 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of beraprost in Chronic Allograft Kidney Disease (CKaD), sponsored by Seoul National University Hospital. Primary endpoints: Graft pathology at 1 year and Serum creatinine at 1 year. Started Jun 2009; status: completed.
02
Drugs
beraprost
03
Conditions
Chronic Allograft Kidney Disease (CKaD)
Beyond the preview
Go deeper on NCT01056835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01056835.